argenx SE

Contributing Author

Recent Articles by argenx SE

Jun-30	argenx Advances Clinical Development of ARGX-119 in Congenital Myasthenic Syndromes ARGX GlobeNewswire
Jun-20	argenx Announces European Commission Approval of VYVGART Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy ARGX GlobeNewswire
Jun-10	argenx Presents New Efgartigimod Data at EULAR 2025 Highlighting Positive Phase 2 Proof-of-Concept Results in Myositis and Sjogren's Disease ARGX GlobeNewswire
Jun-03	argenx to Present at Goldman Sachs 46th Annual Global Healthcare Conference ARGX GlobeNewswire
May-28	argenx Announces Results of Annual General Meeting of Shareholders ARGX GlobeNewswire
May-08	argenx Reports First Quarter 2025 Financial Results and Provides Business Update ARGX GlobeNewswire
May-06	argenx to Present at BofA Securities 2025 Health Care Conference ARGX GlobeNewswire